Exagen Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Exagen's estimated annual revenue is currently $36M per year.(i)
  • Exagen's estimated revenue per employee is $155,000

Employee Data

  • Exagen has 232 Employees.(i)
  • Exagen grew their employee count by 8% last year.

Exagen's People

NameTitleEmail/Phone
1
Chief Innovation OfficerReveal Email/Phone
2
CFOReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Chief Technology OfficerReveal Email/Phone
6
SVP Sales and MarketingReveal Email/Phone
7
Market Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11050M288364%$48.1M$17.5B
Add Company

What Is Exagen?

Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on AVISE testing services, please visit www.AviseTest.com. Read our Social Media Terms of Use here: http://bit.ly/smtou

keywords:N/A

N/A

Total Funding

232

Number of Employees

$36M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Exagen News

2022-04-17 - Exagen (NASDAQ:XGN) Downgraded by Zacks Investment ...

Exagen Inc. is based in Vista, California. “ Get Exagen alerts: A number of other research firms have also issued reports on XGN...

2022-04-17 - Exagen Inc. to Participate in Investor Summit Group's Q2 ...

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing ... Exagen's Chief Financial Officer, will present on Wednesday,...

2022-03-30 - Exagen Inc. Expands In-Network Access with Evolutions ...

SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M2665%N/A
#2
$15M2794%N/A
#3
$54.7M35322%N/A
#4
$79.9M355-6%N/A
#5
$198.4M484-1%N/A